Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04544995
Title Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Pediatric Participants With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

neuroblastoma

osteosarcoma

Ewing sarcoma

Advanced Solid Tumor

adrenocortical carcinoma

rhabdomyosarcoma

Therapies

Dostarlimab-gxly + Niraparib

Age Groups: child
Covered Countries FRA | ESP


No variant requirements are available.